Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IGC Pharma, Inc. | 500,000 | reported | 17 Oct 2025 | tx 28+2,495,736−467,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Oct 2025 | GRANT_AWARD | IGC Pharma, Inc. | 500,000 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 50,000 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 80,000 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 33,333 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 33,333 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 80,000 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 50,000 | 0.00 USD | deriv |
| 25 Sept 2024 | PURCHASE | IGC Pharma, Inc. | 588,235 | 0.34 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 28,500 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 80,000 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 33,334 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 50,000 | 0.00 USD | |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 29,000 | 0.00 USD | |
| 13 Mar 2024 | GRANT_AWARD | IGC Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 13 Mar 2024 | GRANT_AWARD | IGC Pharma, Inc. | 150,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 33,333 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 80,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 50,000 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | IGC Pharma, Inc. | 57,500 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 50,000 | 0.00 USD | |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 33,334 | 0.00 USD | |
| 25 May 2022 | GRANT_AWARD | IGC Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | IGC Pharma, Inc. | 33,334 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | IGC Pharma, Inc. | 200,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | IGC Pharma, Inc. | 240,000 | 0.00 USD | deriv |